The groundbreaking therapy of the medication represents a significant breakthrough in the management of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP https://tirzepatide-peptide109068.bloggactivo.com/41109921/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment